-
Finding Answers in Prostate Cancer
PSMA PET imaging is helping clinicians more accurately stage prostate cancer and provide precision treatment.
by Sandra Gordon
-
Is Chemo-free Treatment Coming for HER2-positive Breast Cancer?
Evidence grows that some people with HER2-positive breast cancer may do well on HER2-targeted therapy alone.
by Myles Starr
-
Germline Genetic Testing Lags Behind Guidelines
Low rates of germline genetic testing in cancer patients means information that could affect treatment isn’t available.
by Jon Kelvey
-
Progress in Lung Cancer
November is Lung Cancer Awareness Month. Here are stories describing lung cancer treatment advances and the experiences of people who have been through a diagnosis.
-
Against All Odds
At age 26, Manny Garcia was diagnosed with and fought pancreatic cancer.
by Karon Warren
-
Finding the ‘Silent Killer’
Strange symptoms led cancer care nurse Eve Spiegel to an ovarian cancer diagnosis.
by Eve Spiegel
-
Making Treatment Decisions
It’s not always clear what to do when cancer progresses. Abigail Johnston shares how she has approached treatment decisions since her metastatic breast cancer diagnosis in 2017.
by Abigail M. Johnston
-
Forward Look
The Promise of Liquid BiopsiesBlood tests that detect traces of cancer cells and tumor DNA help find residual disease after treatment is completed.
by Tara Haelle
-
Forward Look
The Chemotherapy ChoiceAdding an anthracycline to taxane chemotherapy regimens can reduce recurrence risk in early-stage breast cancer, but side effects also factor into treatment decisions.
by Kris Conner
-
Forward Look
Tissue-sparing SurgeryA clinical trial affirms the value of a procedure that preserves more tissue in early-stage lung cancer patients.
by Ashley P. Taylor
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles